Givaudan, CH0010645932

Givaudan stock stands at EUR 4,297.50 with CHF 36.7 billion value

Published on 10/26/2026 at 09:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Givaudan reports CHF 5,891 million in nine-month sales. Givaudan stock costs EUR 4,297.50 on October 26, 2026 before its October 29 event.

Sales and valuation context

  • Givaudan's nine-month sales reached CHF 5,891 million on October 13, 2026.
  • Fragrance and Beauty sales rose 8.8 percent like-for-like in the first nine months of 2026.
  • Givaudan stock trades at EUR 4,297.50 at 9:44 a.m. CEST at Lang & Schwarz on October 26, 2026.
Givaudan CH0010645932 Bauhaus-Plakat mit geometrischer Duftstoff-Welle und Molekülpunkten in Primärfarben und Lavendel, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) was trading at EUR 4,297.50 at Lang & Schwarz on October 26, 2026 at 9:44 a.m. CEST. The Swiss fragrance and flavor supplier had reported CHF 5,891 million in sales for the first nine months of 2026, while its next investor presentation is scheduled for October 29, 2026.

The current valuation context is substantial. The finance data snapshot showed a market capitalization of CHF 36.7 billion and a 52-week range of CHF 2,566.00 to CHF 4,015.00 on October 26, 2026. Givaudan's Swiss primary listing is on the SIX Swiss Exchange under ticker GIVN.

Sales growth favors fragrance

According to Givaudan in its release dated October 13, 2026, group sales increased 5.2 percent like-for-like in the first nine months of 2026. Reported sales rose 2.6 percent in Swiss francs from CHF 5,743 million in the comparable 2025 period.

The mix is the central operating signal. Fragrance and Beauty generated CHF 3,150 million, up 8.8 percent like-for-like, while Taste and Wellbeing produced CHF 2,741 million, up 1.5 percent like-for-like. The company said price increases with customers fully compensated for higher input costs.

What comes next for investors?

The next dated company event is the Zurich investor presentation on October 29, 2026, followed by full-year results on January 27, 2027. Both dates are listed on Givaudan's investor page.

For investors, the contrast between the two divisions matters more than the group total alone. Fragrance and Beauty delivered 8.8 percent like-for-like growth, compared with 1.5 percent for Taste and Wellbeing in the same nine-month period. That gap leaves the October presentation as a test of whether the recovery in flavors can broaden the growth profile.

Price and trading context

Givaudan's euro quotation was trading at EUR 4,297.50 at Lang & Schwarz on October 26, 2026 at 9:44 a.m. CEST. A dated Xetra closing reference was not established, so no daily percentage comparison is stated. The SIX-listed share had a 52-week high of CHF 4,015.00 and a 52-week low of CHF 2,566.00 as of October 26, 2026.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.

Givaudan stock facts

  • Company: Givaudan AG
  • ISIN: CH0010645932
  • WKN: 938427
  • Ticker: GIVN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz as of October 26, 2026, 9:44 a.m. CEST: EUR 4,297.50
  • Market capitalization: CHF 36.7 billion (as of October 26, 2026)
  • 52-week range: CHF 2,566.00-4,015.00 (as of October 26, 2026)
  • Sector / Industry: Materials / Specialty Chemicals
  • Index membership: SMI

Market context: Market report SMI.

More news and analyses on Givaudan stock

Disclaimer...
en | CH0010645932 | GIVAUDAN | boerse | 70413345 | bgmi